SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001415889-16-007182
Filing Date
2016-09-22
Accepted
2016-09-22 13:56:20
Documents
3
Period of Report
2016-09-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vtgn8k_sep222016.htm 8-K 22903
2 PRESS RELEASE, DATED SEPTEMBER 22, 2016 ex99-1.htm EX-99.1 33116
3 vtgn8k_sep222016.jpg GRAPHIC 11249
  Complete submission text file 0001415889-16-007182.txt   72841
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-244-9990
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 161897370
SIC: 2834 Pharmaceutical Preparations